Interpretation and Considerations on the Safety Evaluation of Human Drug Metabolites-Reference-Cited by-同舟云学术

Interpretation and Considerations on the Safety Evaluation of Human Drug Metabolites

Published:2009-06-29 Issue:7 Volume:22 Page:1217-1220
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Atrakchi Aisar H.¹

Affiliation:

1. Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20993

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/tx900124j

Reference36 articles.

1. U.S. Food and Drug AdministrationU.S. Food and Drug Administration Guidances,Center for Drug Evaluation and Research,Rockville, MD; www.fda.gov/cder/guidances.

2. Drug metabolism and pharmacogenetics: the British contribution to fields of international significance

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-in-human study to assess the safety, tolerability, and pharmacokinetics of intravenous SHPL-49 following single- and multiple-ascending-dose administration in healthy adults;Journal of Pharmaceutical and Biomedical Analysis;2024-10

2. A MIST conception: what has been learned from twenty years of human metabolite safety assessment?;Medicinal Chemistry Research;2023-06-13

3. Identification and characterization of the metabolites of moscatilin in mouse, rat, dog, monkey and human hepatocytes by LC–Orbitrap–MS/MS combined with diagnostic fragment ions and accurate mass measurements;Biomedical Chromatography;2022-12-26

4. Identification of the metabolite of ophiopogonanone A by liquid chromatography/quadrupole time‐of‐flight mass spectrometry;Rapid Communications in Mass Spectrometry;2022-04-19

5. Advances in enzymatic oxyfunctionalization of aliphatic compounds;Biotechnology Advances;2021-11